NASDAQ-GS · traded in Congress
Regeneron Pharmaceuticals, REGN
$790.01 -6.01 (-0.76%) Sep 25, 2026 4:01 AM ET
Market value$81.3B
P/E ratio-
Analyst target$857.00
52-week range-
Avg volume740,290
Dividend yield0.47%
Chart
Congress trades in REGN
Members of Congress disclosed 2 transactions in REGN in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 05/15/2026 | Gilbert Cisneros CA31 | Sale | $1,001 - $15,000 | 6/8/2026 filing |
| 02/12/2026 | Julia Letlow LA05 | Purchase | $1,001 - $15,000 | 3/12/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.